share_log

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

4:持股变动声明-董事 TOOVEY STEPHEN
美股sec公告 ·  05/21 20:25
Moomoo AI 已提取核心信息
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
斯蒂芬·图维报告说,2024年5月16日购买了4,000股60度制药(SXTP)普通股。该交易以每股0.223美元的价格完成。此次收购后,Toovey在该公司的直接持股量增加到总共14,000股。该交易被描述为赠款、奖励或其他收购,反映了Toovey在这家制药公司的股份不断增加。
斯蒂芬·图维报告说,2024年5月16日购买了4,000股60度制药(SXTP)普通股。该交易以每股0.223美元的价格完成。此次收购后,Toovey在该公司的直接持股量增加到总共14,000股。该交易被描述为赠款、奖励或其他收购,反映了Toovey在这家制药公司的股份不断增加。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息